June 21 (Reuters) - ABVC Biopharma Inc ABVC.O :
* ABVC BIOPHARMA EXPANDS CO-DEVELOPMENT PARTNERSHIP WITH
RGENE
CORPORATION
* ABVC-UNIT ENTERED CLINICAL DEVELOPMENT SERVICE AGREEMENT
WITH
RGENE TO GUIDE THREE RGENE DRUG PRODUCTS THROUGH COMPLETION OF
PHASE II CLINICAL STUDIES
* ABVC BIOPHARMA INC - UNDER TERMS OF NEW SERVICES
AGREEMENT,
BIOKEY IS ELIGIBLE TO RECEIVE PAYMENTS TOTALING $3.0 MILLION
OVER A 3-YEAR PERIOD
Source text for Eikon: ID:nGNX2z4Hv
Further company coverage: ABVC.O
((Reuters.Briefs@thomsonreuters.com;))